PNC Financial Services Group
STRO icon

PNC Financial Services Group’s Sutro Biopharma STRO Stock Holding History

PNC Financial Services Group’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-62
Closed -$2.06K – 5492
2026
Q2 		$2.06K Hold
62
– – ﹤0.01% 4670
2026
Q1 		$1.54K Hold
62
– – ﹤0.01% 4659
2025
Q4 		$717 Buy
62
+1
+2% +$9 ﹤0.01% 4766
2025
Q3 		$533 Sell
61
-16
-21% -$136 ﹤0.01% 4794
2025
Q2 		$549 Buy
77
+10
+15% +$82 ﹤0.01% 4671
2025
Q1 		$434 Buy
67
+62
+1,240% +$976 ﹤0.01% 4668
2024
Q4 		$94 Hold
5
– – ﹤0.01% 4711
2024
Q3 		$176 Hold
5
– – ﹤0.01% 4690
2024
Q2 		$149 Buy
+5
New +$198 ﹤0.01% 4699

Other funds holding STRO

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

PNC Financial Services Group's STRO Position: Q3 2026 in Review

PNC Financial Services Group sold out of Sutro Biopharma (STRO) in Q3 2026, closing a stake of 62 shares — an estimated $2.06K sold.

PNC Financial Services Group first reported a position in STRO in Q2 2024 and held it in 9 quarters. The position peaked at $2.06K in Q2 2026. 33 funds tracked by Wall St. Rank hold STRO as of Q3 2026.

  • PNC Financial Services Group reported no remaining Sutro Biopharma position as of Q3 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 62 Sutro Biopharma shares in Q3 2026, an estimated $2.06K.
  • PNC Financial Services Group first reported a position in Sutro Biopharma in Q2 2024 and held it in 9 quarters.
  • PNC Financial Services Group's Sutro Biopharma position peaked at $2.06K in Q2 2026.
  • 33 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.